{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:32:25Z","timestamp":1793043145917,"version":"4.5.0"},"reference-count":46,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,3,30]]},"DOI":"10.1536\/ihj.20-315","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T22:06:37Z","timestamp":1614981997000},"page":"350-358","source":"Crossref","is-referenced-by-count":27,"title":["HIF-1\/AKT Signaling-Activated PFKFB2 Alleviates Cardiac Dysfunction and Cardiomyocyte Apoptosis in Response to Hypoxia"],"prefix":"10.1536","volume":"62","author":[{"given":"Juanyu","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Cardiology, Central Hospital Affiliated to Shandong First Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital Affiliated to Shandong First Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital Affiliated to Shandong First Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Hospital of Shandong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihua","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital Affiliated to Shandong First Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Liu CY, Zhang YH, Li RB, <i>et al<\/i>. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun 2018; 9: 29.","DOI":"10.1038\/s41467-017-02280-y"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Frangogiannis NG. Pathophysiology of Myocardial Infarction. Compr Physiol 2015; 5: 1841-75.","DOI":"10.1002\/cphy.c150006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hao Y, Yuan H, Yu H. Downregulation of miR-483-5p decreases hypoxia-induced injury in human cardiomyocytes by targeting MAPK3. Cell Mol Biol Lett 2020; 25: 20.","DOI":"10.1186\/s11658-020-00213-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wei Q, Zhou HY, Shi XD, Cao HY, Qin L. Long Noncoding RNA NEAT1 Promotes Myocardiocyte Apoptosis and Suppresses Proliferation Through Regulation of miR-129-5p. J Cardiovasc Pharmacol 2019; 74: 535-41.","DOI":"10.1097\/FJC.0000000000000741"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kanazawa H, Imoto K, Okada M, Yamawaki H. Canstatin inhibits hypoxia-induced apoptosis through activation of integrin\/focal adhesion kinase\/Akt signaling pathway in H9c2 cardiomyoblasts. PLoS One 2017; 12: e0173051.","DOI":"10.1371\/journal.pone.0173051"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gao X, Zhang H, Zhuang W, <i>et al<\/i>. PEDF and PEDF-derived peptide 44mer protect cardiomyocytes against hypoxia-induced apoptosis and necroptosis via anti-oxidative effect. Sci Rep 2014; 4: 5637.","DOI":"10.1038\/srep05637"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zhang Z, Li H, Chen S, Li Y, Cui Z, Ma J. Knockdown of MicroRNA-122 Protects H9c2 Cardiomyocytes from Hypoxia-Induced Apoptosis and Promotes Autophagy. Med Sci Monit 2017; 23: 4284-90.","DOI":"10.12659\/MSM.902936"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Heywood SE, Richart AL, Henstridge DC, <i>et al<\/i>. High-density lipoprotein delivered after myocardial infarction increases cardiac glucose uptake and function in mice. Sci Transl Med 2017; 9: eaam6084.","DOI":"10.1126\/scitranslmed.aam6084"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ham PB 3rd, Raju R. Mitochondrial function in hypoxic ischemic injury and influence of aging. Prog Neurobiol 2017; 157: 92-116.","DOI":"10.1016\/j.pneurobio.2016.06.006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol 2014; 9: 47-71.","DOI":"10.1146\/annurev-pathol-012513-104720"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Williams AL, Khadka V, Tang M, <i>et al<\/i>. HIF1 mediates a switch in pyruvate kinase isoforms after myocardial infarction. Physiol Genomics 2018; 50: 479-94.","DOI":"10.1152\/physiolgenomics.00130.2017"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hu B, Ying X, Wang J, <i>et al<\/i>. Identification of a Tumor-Suppressive Human-Specific MicroRNA within the FHIT Tumor-Suppressor Gene. Cancer Res 2014; 74: 2283-94.","DOI":"10.1158\/0008-5472.CAN-13-3279"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Novellasdemunt L, Tato I, Navarro-Sabate A, <i>et al<\/i>. Akt-dependent activation of the heart 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase (PFKFB2) isoenzyme by amino acids. J Biol Chem 2013; 288: 10640-51.","DOI":"10.1074\/jbc.M113.455998"},{"key":"14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/prot.25204","volume":"85","year":"2017","unstructured":"14. Crochet RB, Kim JD, Lee H, <i>et al<\/i>. Crystal structure of heart 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase (PFKFB2) and the inhibitory influence of citrate on substrate binding. Proteins 2017; 85: 117-24.","journal-title":"Proteins Structure Function and Genetics","ISSN":"https:\/\/id.crossref.org\/issn\/0887-3585","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Minchenko O, Opentanova I, Caro J. Hypoxic regulation of the 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett 2003; 554: 264-70.","DOI":"10.1016\/S0014-5793(03)01179-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ellis R, Katerelos M, Choy SW, <i>et al<\/i>. Increased expression and phosphorylation of 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia. J Transl Med 2019; 17: 60.","DOI":"10.1186\/s12967-019-1806-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Williams DM, Shroff GR, Leclaire MM, Leatherman JW. Shock After Myocardial Infarction. Chest 2018; 153: e29-31.","DOI":"10.1016\/j.chest.2017.10.045"},{"key":"18","unstructured":"18. Lim GB. Acute coronary syndromes: Supplemental oxygen in myocardial infarction. Nat Rev Cardiol 2017; 14: 632."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Moon JS, Jin WJ, Kwak JH, <i>et al<\/i>. Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase 2 in prostate cancer cells. Biochem J 2011; 433: 225-33.","DOI":"10.1042\/BJ20101104"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Houles T, Gravel SP, Lavoie G, <i>et al<\/i>. RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma. Cancer Res 2018; 78: 2191-204.","DOI":"10.1158\/0008-5472.CAN-17-2215"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sousa Fialho MDL, Abd Jamil AH, Stannard GA, Heather LC. Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease. Biochim Biophys Acta Mol Basis Dis 2019; 1865: 831-43.","DOI":"10.1016\/j.bbadis.2018.09.024"},{"key":"22","unstructured":"22. Zhang Z, Yao L, Yang J, Wang Z, Du G. PI3K\/Akt and HIF1 signaling pathway in hypoxiaischemia (Review). Mol Med Rep 2018; 18: 3547-54."},{"key":"23","unstructured":"23. Xie Y, Shi X, Sheng K, <i>et al<\/i>. PI3K\/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review). Mol Med Rep 2019; 19: 783-91."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Saxena A, Russo I, Frangogiannis NG. Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges. Transl Res 2016; 167: 152-66.","DOI":"10.1016\/j.trsl.2015.07.002"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. The L. Acute myocardial infarction in women. Lancet 2016; 387: 506.","DOI":"10.1016\/S0140-6736(16)00267-1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Yang D, Yu J, Liu HB, <i>et al<\/i>. The long non-coding RNA TUG1-miR-9a-5p axis contributes to ischemic injuries by promoting cardiomyocyte apoptosis via targeting KLF5. Cell Death Dis 2019; 10: 908.","DOI":"10.1038\/s41419-019-2138-4"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nederlof R, Eerbeek O, Hollmann MW, Southworth R, Zuurbier CJ. Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart. Br J Pharmacol 2014; 171: 2067-79.","DOI":"10.1111\/bph.12363"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Wang Q, Donthi RV, Wang J, <i>et al<\/i>. Cardiac phosphatase-deficient 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia. Am J Physiol Heart Circ Physiol 2008; 294: H2889-97.","DOI":"10.1152\/ajpheart.91501.2007"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Aksentijevic D, Lygate CA, Makinen K, <i>et al<\/i>. High-energy phosphotransfer in the failing mouse heart: role of adenylate kinase and glycolytic enzymes. Eur J Heart Fail 2010; 12: 1282-9.","DOI":"10.1093\/eurjhf\/hfq174"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. She L, Tu H, Zhang YZ, <i>et al<\/i>. Inhibition of Phosphoglycerate Mutase 5 Reduces Necroptosis in Rat Hearts Following Ischemia\/Reperfusion Through Suppression of Dynamin-Related Protein 1. Cardiovasc Drugs Ther 2019; 33: 13-23.","DOI":"10.1007\/s10557-018-06848-8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Magadum A, Singh N, Kurian AA, <i>et al<\/i>. Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration. Circulation 2020; 141: 1249-65.","DOI":"10.1161\/CIRCULATIONAHA.119.043067"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Shah A, Matsumura N, Quon A, Morton JS, Dyck JRB, Davidge ST. Cardiovascular susceptibility to in vivo ischemic myocardial injury in male and female rat offspring exposed to prenatal hypoxia. Clin Sci (Lond) 2017; 131: 2303-17.","DOI":"10.1042\/CS20171122"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Stub D, Smith K, Bernard S, <i>et al<\/i>. Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction. Circulation 2015; 131: 2143-50.","DOI":"10.1161\/CIRCULATIONAHA.114.014494"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Smolders VF, Zodda E, Quax PHA, <i>et al<\/i>. Metabolic Alterations in Cardiopulmonary Vascular Dysfunction. Front Mol Biosci 2018; 5: 120.","DOI":"10.3389\/fmolb.2018.00120"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Mallet RT, Manukhina EB, Ruelas SS, Caffrey JL, Downey HF. Cardioprotection by intermittent hypoxia conditioning: evidence, mechanisms, and therapeutic potential. Am J Physiol Heart Circ Physiol 2018; 315: H216-32.","DOI":"10.1152\/ajpheart.00060.2018"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Bartman CM, Oyama Y, Brodsky K, <i>et al<\/i>. Intense light-elicited upregulation of miR-21 facilitates glycolysis and cardioprotection through Per2-dependent mechanisms. PLoS One 2017; 12: e0176243.","DOI":"10.1371\/journal.pone.0176243"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wang ZC, Wang ZZ, Ma HJ, Wang CC, Wang HT. Attenuation of the hypoxia-induced miR-34a protects cardiomyocytes through maintenance of glucose metabolism. Biochem Biophys Res Commun 2018; 498: 375-81.","DOI":"10.1016\/j.bbrc.2017.06.030"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Manning JR, Thapa D, Zhang M, <i>et al<\/i>. Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt\/mTORC2 signaling. Biochem J 2019; 476: 1713-24.","DOI":"10.1042\/BCJ20190302"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Cole MA, Abd Jamil AH, Heather LC, <i>et al<\/i>. On the pivotal role of PPARalpha in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury. FASEB J 2016; 30: 2684-97.","DOI":"10.1096\/fj.201500094R"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Yang C, Liu X, Yang F, <i>et al<\/i>. Mitochondrial phosphatase PGAM5 regulates Keap1-mediated Bcl-xL degradation and controls cardiomyocyte apoptosis driven by myocardial ischemia\/reperfusion injury. In Vitro Cell Dev Biol Anim 2017; 53: 248-57.","DOI":"10.1007\/s11626-016-0105-2"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Choudhry H, Harris AL. Advances in Hypoxia-Inducible Factor Biology. Cell Metab 2018; 27: 281-98.","DOI":"10.1016\/j.cmet.2017.10.005"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Balamurugan K. HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer 2016; 138: 1058-66.","DOI":"10.1002\/ijc.29519"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Cerychova R, Pavlinkova G. HIF-1, Metabolism, and Diabetes in the Embryonic and Adult Heart. Front Endocrinol (Lausanne) 2018; 9: 460.","DOI":"10.3389\/fendo.2018.00460"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol 2014; 76: 39-56.","DOI":"10.1146\/annurev-physiol-021113-170322"},{"key":"45","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/01.CIR.103.19.2387","volume":"103","year":"2001","unstructured":"45. Kakinuma Y, Miyauchi T, Yuki K, Murakoshi N, Goto K, Yamaguchi I. Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1alpha induced for impaired myocardial energy metabolism. Circulation 2001; 103: 2387-94.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Beltran C, Pardo R, Bou-Teen D, <i>et al<\/i>. Enhancing Glycolysis Protects against Ischemia-Reperfusion Injury by Reducing ROS Production. Metabolites 2020; 10: 132.","DOI":"10.3390\/metabo10040132"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/2\/62_20-315\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T03:59:55Z","timestamp":1617422395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/2\/62_20-315\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-315","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]}}}